Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Capturing chemotherapy drugs before they can cause side effects

Although chemotherapy can kill cancer cells very effectively, healthy cells also suffer.

If doctors could remove excess chemotherapy drugs from a patient's bloodstream after the medicines have done their job, they might reduce side effects such as hair loss and nausea.

Now, researchers have developed a 3D-printed device that absorbs excess chemo drugs before they spread throughout the body.

They report their results in ACS Central Science.

Doxorubicin, like many chemotherapy drugs, kills more tumour cells when given at higher doses.

However, most patients cannot tolerate large amounts of the drug because it can cause heart failure, among other side effects.

Nitash Balsara, Steven Hetts, Joseph DeSimone, Hee Jeung Oh and colleagues wondered if they could make a device that would filter out doxorubicin from blood at locations outside of the tumour to reduce the likelihood that the drug would harm healthy cells.

The researchers used a 3D printer to fabricate tiny cylinders made of poly(ethylene glycol) diacrylate.

Inside the cylinders was a square lattice structure that would allow blood cells to pass through it, with a copolymer coating that binds to doxorubicin.

The researchers tested these absorbers in pigs, inserting them into a vein.

When they injected doxorubicin into the same vein, the drug flowed in the bloodstream to the device.

By measuring the doxorubicin concentration in the vein at a location after the absorber, the researchers determined that it captured about 64 percent of the drug from the bloodstream.

The device could open a new route to help patients fight cancer, enabling reduced side effects or an increased chemotherapy dose, the researchers say.

Source: ACS

Photo credit: Hee Jeung Oh

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation